Noida: A 19-year-old boy from Uttar Pradesh’s Sonbhadra district has survived a life-threatening medical crisis caused by Haemophilia, a rare inherited blood disorder, after weeks of intensive treatment at Noida Child PGI. The boy, identified as Master Sumit, was admitted in early Dec 2025 in critical condition with severe swelling in his legs, internal bleeding and haemorrhagic shock. Doctors later confirmed that he was suffering from Haemophilia A, a genetic disorder in which the body lacks Factor VIII, a protein essential for blood clotting. In such cases, even minor injuries can result in prolonged bleeding or dangerous internal haemorrhages. The disorder affects nearly one in 20,000 children, making early diagnosis difficult, particularly in rural and resource-poor areas. “Sumit, who belongs to a below-poverty-line (BPL) family from Auri village in Sonbhadra, silently lived with the condition for years. His family background was marked by severe hardship. Following the death of his father, his mother developed serious mental health issues, leaving Sumit and his siblings to shoulder the responsibility of running the household through informal work with limited income. Like many children with inherited bleeding disorders in rural India, Sumit’s early symptoms went unrecognised. Persistent leg pain and swelling during his school years were treated by local practitioners without identifying the underlying cause. Social stigma and lack of awareness further delayed timely medical intervention,” a doctor at Noida Child PGI said. According to doctors, Sumit was first diagnosed in 2023 when he travelled alone to a tertiary care hospital in Delhi with help from one of his sisters. He was treated with Factor VIII replacement therapy and continued treatment through government welfare schemes and a haemophilia support group. In Nov 2025, his condition worsened again. He developed recurrent internal bleeding, including blood in his stools, suggesting a lower gastrointestinal haemorrhage. Fear and embarrassment delayed reporting of symptoms. On Dec 2, he was brought to Noida Child PGI in haemorrhagic shock, with dangerously low blood pressure and severe blood loss.Doctors soon identified a serious complication, inhibitor-positive haemophilia. “In this condition, the body develops antibodies that neutralise standard clotting factor treatment, making routine therapy ineffective. This was a major challenge, as conventional Factor VIII was not working,” doctors involved in his care said. Sumit required high-dependency care, inotropic support, oxygen therapy and multiple blood transfusions. He was treated with advanced bypassing agents, including recombinant Factor VIIa (rFVIIa), FEIBA and Emicizumab, provided under govt support through the National Health Mission. Multiple departments worked together to control the bleeding. “From Dec 13 onwards, Sumit showed steady improvement. His bleeding stopped, vital parameters stabilised, and after careful monitoring, he was discharged. Follow-up visits confirmed that he remained stable,” the doctor said.
